Literature DB >> 12519085

The inflammatory macrophage: a story of Jekyll and Hyde.

Jeremy S Duffield1.   

Abstract

Recent investigations have highlighted new roles for the macrophage (Mphi) in the biology of inflammation. Selective depletion of Mphis from inflamed sites has confirmed their predominant role in immune-mediated damage. The components of this injury have been dissected. Mphis mediate death of stromal, parenchymal and other immune cells by engaging the death programme, resulting in apoptosis. In addition, Mphis induce destruction of matrix and extracellular structures both directly and indirectly by inducing stromal cells to release matrix metalloproteinases. However, there is another side to the inflammatory Mphi. Evidence is provided that Mphis at the same sites possess the ability to aid cell proliferation, secrete and stabilize new matrix components and induce resident cells to secrete matrix components themselves. Mphi phagocytosis of apoptotic cells brings about a change from the cell-killing matrix-degrading cell to the matrix-generating cell-proliferating tissue-healing cell. Just as both Mphi types are necessary at the inflamed site, the right balance of these two populations is required for healing and resolution. Evidence of excessive inflammation as a manifestation of impaired phagocytosis of apoptotic cells emphasizes that defects in the transition from one Mphi type to another may account for the uncontrolled excessive inflammation seen in disease. Recent insights into the mechanisms by which apoptotic cells signal the change of function to the Mphi offer the prospect of novel targets for manipulation of Mphis in the inflamed tissue.

Entities:  

Mesh:

Year:  2003        PMID: 12519085     DOI: 10.1042/

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  120 in total

1.  Short-chain fatty acids suppress lipopolysaccharide-induced production of nitric oxide and proinflammatory cytokines through inhibition of NF-κB pathway in RAW264.7 cells.

Authors:  Tengfei Liu; Jing Li; Yuxin Liu; Nan Xiao; Haitao Suo; Kun Xie; Chunliu Yang; Chen Wu
Journal:  Inflammation       Date:  2012-10       Impact factor: 4.092

2.  Intracellular pathogen sensor NOD2 programs macrophages to trigger Notch1 activation.

Authors:  Kushagra Bansal; Kithiganahalli N Balaji
Journal:  J Biol Chem       Date:  2010-12-14       Impact factor: 5.157

3.  In vivo targeting of alveolar macrophages via RAFT-based glycopolymers.

Authors:  Eun-Ho Song; Matthew J Manganiello; Yu-Hua Chow; Bilal Ghosn; Anthony J Convertine; Partick S Stayton; Lynn M Schnapp; Daniel M Ratner
Journal:  Biomaterials       Date:  2012-07-06       Impact factor: 12.479

4.  Leukocytes induce epithelial to mesenchymal transition after unilateral ureteral obstruction in neonatal mice.

Authors:  Bärbel Lange-Sperandio; Agnes Trautmann; Oliver Eickelberg; Aparna Jayachandran; Stephan Oberle; Florian Schmidutz; Barbara Rodenbeck; Meike Hömme; Richard Horuk; Franz Schaefer
Journal:  Am J Pathol       Date:  2007-08-03       Impact factor: 4.307

5.  Mac the knife? Macrophages- the double-edged sword of hepatic fibrosis.

Authors:  Scott L Friedman
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

6.  Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair.

Authors:  Jeremy S Duffield; Stuart J Forbes; Christothea M Constandinou; Spike Clay; Marina Partolina; Srilatha Vuthoori; Shengji Wu; Richard Lang; John P Iredale
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

7.  The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages.

Authors:  Shanjin Cao; Jianguo Liu; Lihua Song; Xiaojing Ma
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

8.  Amniotic membrane induces apoptosis of interferon-gamma activated macrophages in vitro.

Authors:  Wei Li; Hua He; Tetsuya Kawakita; Edgar M Espana; Scheffer C G Tseng
Journal:  Exp Eye Res       Date:  2005-08-16       Impact factor: 3.467

9.  Imbalances between interleukin-1 and tumor necrosis factor agonists and antagonists in stable COPD.

Authors:  Elizabeth Sapey; Ali Ahmad; Darren Bayley; Paul Newbold; Noel Snell; Paul Rugman; Robert A Stockley
Journal:  J Clin Immunol       Date:  2009-03-17       Impact factor: 8.317

10.  Regulation of caveolin-1 expression, nitric oxide production and tissue injury by tumor necrosis factor-alpha following ozone inhalation.

Authors:  Ladan Fakhrzadeh; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2007-11-22       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.